A Phase Ib/II Study of BEZ235 and Trastuzumab in Patients With HER2-positive Breast Cancer Who Failed Prior to Trastuzumab

Clinical trial NCT01471847 · COMPLETED

Trial details

NCT number: NCT01471847
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Locally Advance Breast Cancer (LABC)Metastatic Breast Cancer (MBC)

Start date: 2012-02-01
Primary completion: 2012-06-01
Enrollment: 5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.